Skip to main content
. 2014 Jan 23;9(1):e85905. doi: 10.1371/journal.pone.0085905

Table 5. Prevalence of ATLI in patients according to acetylator status.

Acetylator status: PatientsWithATLI Patients withelevated ALT,AST, or bilrubin Patients with normalALT, AST andbilirubin levels Total PrevalenceofATLI % Prevalenceratio(95% CI) P-value#
Rapid (RA) 9 41 287 337 2.70% 1 0.0616
Intermediate (IA) 34 118 667 819 4.20% 1.60 (0.75,3.20)
Slow (SA) 28 79 422 529 5.30% 2.00 (0.95,4.20)
not typed 18 59 482 559 3.20%
TOTAL 89 297 1858 2244 4.00%
#

Cochrane-Armitage test for trend.